Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

9.7%

3 terminated out of 31 trials

Success Rate

86.4%

-0.1% vs benchmark

Late-Stage Pipeline

13%

4 trials in Phase 3/4

Results Transparency

32%

6 of 19 completed with results

Key Signals

6 with results86% success

Data Visualizations

Phase Distribution

25Total
Not Applicable (9)
Early P 1 (1)
P 1 (3)
P 2 (8)
P 3 (3)
P 4 (1)

Trial Status

Completed19
Unknown5
Terminated3
Recruiting2
Enrolling By Invitation1
Active Not Recruiting1

Trial Success Rate

86.4%

Benchmark: 86.5%

Based on 19 completed trials

Clinical Trials (31)

Showing 20 of 20 trials
NCT02270814Phase 2Active Not Recruiting

Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma

NCT04470024Phase 1RecruitingPrimary

Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC

NCT03102229Not ApplicableCompletedPrimary

Real-time Activity Monitoring to Prevent Admissions During RadioTherapy

NCT03853655Not ApplicableCompleted

Adjuvant Radiotherapy in Early Stage Oral Cancers

NCT05678348Early Phase 1Completed

Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT04865731Phase 2CompletedPrimary

Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer

NCT06991309Not ApplicableCompleted

Mindfulness-based Stress Reduction Effects on Depression, Anxiety and Internalized Stigma Compared With Treatment-As-Usual Among Head and Neck Cancer Patients

NCT02573493Phase 2Completed

Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)

NCT06672471Not ApplicableEnrolling By Invitation

Post-Operative Antibiotic Efficacy in Clean Contaminated Head and Neck Surgery: A Randomized Controlled Trial

NCT04444869Phase 2RecruitingPrimary

Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer

NCT02557048Unknown

Head and Neck Cancer in Children: A Retrospective Study

NCT04880148Not ApplicableUnknownPrimary

The Effectiveness of a Thyme and Honey Spray for Oral Toxicities

NCT02442336Not ApplicableCompletedPrimary

A Web-Based Multimedia Intervention for Head and Neck Cancer Patients

NCT03620084Not ApplicableUnknownPrimary

Effects of Expiratory Muscle Strength Training on Airway Protection and Swallowing in Chronic Dysphagia After Radiation Therapy

NCT03297957Not ApplicableTerminated

Fluorescence Imaging in Head and Neck Cancer

NCT00684385Unknown

An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck

NCT00798655Phase 2Completed

Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer

NCT01917942Phase 3CompletedPrimary

Radiotherapy With Humidification in Head And Neck Cancer

NCT00256295Phase 2TerminatedPrimary

Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer

NCT01347281Not ApplicableCompletedPrimary

PET With [18F]HX4 in Head and Neck Cancer

Scroll to load more

Research Network

Activity Timeline